Results 91 to 100 of about 17,699 (240)

Advances in leishmaniasis.

open access: yes, 2005
Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).
Berman, Jonathan D   +3 more
core   +1 more source

Unveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in Leishmania Infection

open access: yesJournal of Immunology Research, Volume 2025, Issue 1, 2025.
Leishmaniasis is a group of parasitic diseases whose etiological agent is the protozoa Leishmania. These diseases afflict impoverished populations in tropical and subtropical regions and affect wild and domestic animals. Canine leishmaniasis is a global disease mostly caused by L. infantum.
Ana Valério-Bolas   +14 more
wiley   +1 more source

Cutaneous Leishmaniasis (CL) in Saudi Arabia: Current Status [PDF]

open access: yes, 2014
Cutaneous leishmaniasis (CL) is a major tropical infection of public health importance. It is caused by a group of protozoan intracellular parasites. Several factors contribute to the prevalence and transmission of CL.
Zakai, H. A. (Haytham)
core   +1 more source

Opportunities and challenges for modelling epidemiological and evolutionary dynamics in a multihost, multiparasite system: Zoonotic hybrid schistosomiasis in West Africa [PDF]

open access: yes, 2017
Multihost multiparasite systems are evolutionarily and ecologically dynamic, which presents substantial trans‐disciplinary challenges for elucidating their epidemiology and designing appropriate control.
Borlase, A, Rudge, J W, Webster, J P
core   +4 more sources

The Impact of Ivermectin on Immune Response and Wound Healing in a Mouse Model Infected With Leishmania major

open access: yesJournal of Tropical Medicine, Volume 2025, Issue 1, 2025.
Background:​ Understanding the immune pathogenesis mechanisms of leishmaniasis is crucial for developing effective therapeutic interventions. In this study, we investigated the effect of ivermectin (IVE) on the expression of transcription factors GATA‐binding protein 3 (GATA‐3), T‐bet, and ROR‐γt as well as wound healing Leishmania infection.
Abdolbaset Rahmani   +6 more
wiley   +1 more source

Incidence of Trypanosoma cruzi infection in two Guatemalan communities.

open access: yes, 2004
The prevalence of human infection by Trypanosoma cruzi was assessed using an enzyme-linked immunosorbent assay (ELISA) in a serological survey in 1998 of 2 rural communities (SMH and PS) in Guatemala.
Davies, C   +6 more
core   +1 more source

Identification of Leishmania Species Isolated from Human Cutaneous Leishmaniasis, using Random Amplified Polymorphic DNA (RAPD-PCR) [PDF]

open access: yesIranian Journal of Public Health, 2004
This cross-sectional study was designed to isolate of Leishmania spp from cutaneous leishmaniasis patients and characterized them by RAPD-PCR technique.
H Hajjaran   +7 more
doaj   +2 more sources

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy—A retrospective analysis

open access: gold, 2021
Suzette Kämink   +10 more
openalex   +2 more sources

Molecular and parasitological study of cutaneous leishmaniasis in Bushehr province, southwest of the Islamic Republic of Iran: a cross-sectional study during 2009–2012 [PDF]

open access: yes, 2015
Cutaneous leishmaniasis (CL) is one of the most important parasitic disease in Iran. CL is distributed among more than half of 31 provinces of Iran.
Charehdar, Soroor   +8 more
core   +2 more sources

Leishmania tropica: Another Etiological Agent of Canine Visceral Leishmaniasis in Iran. [PDF]

open access: yesIranian Journal of Public Health, 2007
Background: Dogs have been previously reported to be reservoirs of Leishmania infantum as the etiological agent of human visceral leishmaniasis in Iran. We report a case of canine visceral leishmaniasis (VL) caused by L.
H Hajjaran   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy